LYB

LyondellBasell Industries presents a contrarian profile within the chemicals sector, with systematic screening revealing significant operational headwinds alongside defensive valuation characteristics. Trading at $74.13 with a market capitalization of $24.2 billion, the company currently reports negative profitability metrics including ROE of -7.41% and net margin of -2.66%, while the TTM EPS stands at -$2.45. The price-to-sales ratio of 0.82 and price-to-book of 1.38 position LYB among the more attractively valued large-cap chemical manufacturers on traditional metrics.

Fundamental screening highlights several structural considerations:

• The 22.02% year-over-year revenue decline reflects cyclical pressure in petrochemical markets, yet the company maintains a current ratio of 1.77, indicating adequate near-term liquidity management
• Beta of 0.38 demonstrates historically lower volatility relative to broader equity markets, appealing to models prioritizing capital preservation during market stress
• Book value per share of $31.30 suggests the stock trades at approximately 2.4x book value, creating potential mean-reversion opportunities if operational performance stabilizes
• Debt-to-equity ratio of 1.28 falls within manageable parameters for capital-intensive chemical operations, though the negative operating margin of -1.01% raises questions about leverage sustainability

The research perspective emphasizes execution risk tied to margin recovery in an environment of compressed spreads between feedstock costs and finished product pricing. The gross margin of 9.2% versus negative operating margin indicates overhead absorption challenges. Relative to European-listed peers including ESNT.L and ZTF.L, LyondellBasell's established North American manufacturing footprint and integrated value chain provide geographical diversification that quantitative screens may favor during regional demand divergence.